IL1RL1 and breast carcinoma: Furthermore, both IL-33 and IL-25 have been shown to promote angiogenesis which also contributes to metastasis, and genetic deletion of ST2 reduced VEGF expression and tumour burden in mouse breast cancer [179–181].